A
$ Value
$0
Shares
33,099
Price
$0
Filed
Apr 2
Insider
Name
Smith Stan
Title
—
CIK
0001913199
Roles
Director
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Derivative
Ownership
Indirect
Equity Swap
No
Shares After
33,099
Footnotes
The stock options, granted on March 31, 2026 pursuant to the MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date. | These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
Filing Info
Smith Stan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | MAIA | A | $0 |
| 2025-12-31 | MAIA | A | $0 |
| 2025-12-22 | MAIA | ▲ | $70K |
| 2025-12-22 | MAIA | ▲ | $78K |
| 2025-12-05 | MAIA | ▲ | $5K |
| 2025-12-05 | MAIA | ▲ | $5K |
| 2025-12-05 | MAIA | ▲ | $5K |
| 2025-11-26 | MAIA | ▲ | $16K |
| 2025-11-25 | MAIA | ▲ | $15K |
| 2025-11-24 | MAIA | ▲ | $10K |
Other Insiders at MAIA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CHAOUKI STEVEN M | — | — | 2026-03-31 |
|
Gryaznov Sergei
Chief Scientific Officer
|
— | — | 2026-04-10 |
| Guerrero Ramiro | — | — | 2026-03-31 |
|
Vitoc Vlad
Chief Executive Officer
|
— | — | 2026-04-10 |
| Louie Ngar Yee | — | — | 2026-03-31 |
| Luput Cristian | — | — | 2026-03-31 |
| Theagene Jean-Manasse | — | — | 2026-03-31 |
|
Himmelreich Jeffrey C
Head of Finance
|
— | — | 2026-04-10 |